Antiretroviral therapy refusal among newly diagnosed HIV-infected adults. - Test2 - elhamkhani - TriplyDB

Antiretroviral therapy refusal among newly diagnosed HIV-infected adults.

Antiretroviral therapy refusal among newly diagnosed HIV-infected adults.

http://www.wikidata.org/entity/Q35737611

about

Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis Consumption of Sutherlandia frutescens by HIV-Seropositive South African Adults: An Adaptive Double-Blind Randomized Placebo Controlled Trial Addressing the Achilles' heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation.Predictors of delayed antiretroviral therapy initiation, mortality, and loss to followup in HIV infected patients eligible for HIV treatment: data from an HIV cohort study in India.Health-related quality of life dynamics of HIV-positive South African women up to ART initiation: evidence from the CAPRISA 002 acute infection cohort study 'If I am given antiretrovirals I will think I am nearing the grave': Kenyan HIV serodiscordant couples' attitudes regarding early initiation of antiretroviral therapy.Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review.Effects of high CD4 cell counts on death and attrition among HIV patients receiving antiretroviral treatment: an observational cohort study Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships Bioethical challenges with HIV treatment as prevention HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.HIV treatment as prevention: the utility and limitations of ecological observation.Who starts? Factors associated with starting antiretroviral therapy among eligible patients in two, public HIV clinics in Lilongwe, Malawi.Integration of antiretroviral therapy services into antenatal care increases treatment initiation during pregnancy: a cohort study Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study Modeling the implementation of universal coverage for HIV treatment as prevention and its impact on the HIV epidemic.Harnessing poverty alleviation to reduce the stigma of HIV in Sub-Saharan Africa.Socioeconomic gradients in internalized stigma among 4,314 persons with HIV in sub-Saharan Africa.Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis The ethics of talking about 'HIV cure'Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study.Simplified HIV Testing and Treatment in China: Analysis of Mortality Rates Before and After a Structural Intervention.Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda.Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes.Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies.Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.Evidence for the reliability and validity of the internalized AIDS-related stigma scale in rural Uganda Changing Antiretroviral Eligibility Criteria: Impact on the Number and Proportion of Adults Requiring Treatment in Swaziland Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model.Self-care practices and experiences of people living with HIV not receiving antiretroviral therapy in an urban community of Lusaka, Zambia: implications for HIV treatment programmes PrEP as Peri-conception HIV Prevention for Women and Men.Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART One in 4 HIV-Positive South Africans Awaiting ART Initiation Report Condomless Sex With a Serodiscordant Partner.Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.A Framework for Health Communication Across the HIV Treatment Continuum.

P2860

Q26830838-A4F59AD2-7A3D-4BF5-879F-FF6AABABF89A Q28546632-63DF9F1A-5739-492B-AF79-30DDBED40958 Q30363571-F26A75DA-71BC-490B-9AD5-FBD8E1B2F797 Q30704115-A4E8800D-0162-403E-B50F-1DE20C57F472 Q33610865-169ABDFC-8054-4FD9-8A2A-DDAF6BEF0125 Q33693690-95781C9E-7642-460E-B244-5288178D7FB9 Q33717359-7FE085C1-8B17-4112-BAAC-224FCA399F0C Q33784615-BF40F6A4-622F-4B5A-93E7-7253461B5869 Q33831463-82F59530-AF25-40FE-B2B2-8643D8A0D921 Q34077711-249AC47F-CFD9-45B4-ACBE-D6C5EF33F77F Q34339517-596539F1-94AF-4E81-888A-724C11D79B66 Q34339523-0A3A6EF7-5DFA-47F1-93FE-E78862D24152 Q34339533-2D70FC07-C960-45F0-A8D5-67FB9C107E8C Q34506072-63E775C7-662D-49A3-833D-0EA14CD9DDD9 Q34733803-0C3707C5-891B-43D4-BB49-CC65AA6EBB9C Q34988296-AFFBB7B3-197D-416E-A461-231047F23A9C Q34993280-97A71DCC-E855-4376-93AD-0138F152E354 Q35062601-19662CA2-583F-489C-9FE3-BD785481A8BC Q35130632-8725C525-1664-4DAD-9C2E-B3518C5025C6 Q35197266-1B75DCD1-4BF5-4754-81FA-3A5504D775EA Q35226119-F7C02FB2-4E24-4005-BB97-BC2F9F9622C9 Q35370765-B2C87049-E648-4D08-B9A9-EF7E85A1874D Q35766649-F49DE39C-EDD6-4957-BE37-E90633C02820 Q35875751-ED55DB81-2081-4E79-B846-3EC0EEC08175 Q36070585-1513A83A-1ED1-4A82-82E6-8530FDFBB12A Q36098544-DE480624-940B-42C6-AB41-F166186E5D2E Q36171488-50206DC4-08B5-4BD2-BFA5-B8D6E8A7BEBA Q36188123-2A4ADD1B-352A-48E1-BD91-AAB51FCEB6AA Q36408945-CCF12447-1BF6-42C4-8033-2EDBF417B7C4 Q36421733-85A29F3B-6F23-4AA6-A61D-F3F9BDD251FD Q36576582-AF358316-270B-4370-86EA-F0303A1F34AC Q36602040-ADDEBA44-CAAF-4809-8E48-08D6647392EE Q36825312-1DD2AA57-EA42-44FB-85D6-38270B872509 Q36853160-BD61164D-DC2B-4A48-A8DC-65C73F7F36B7 Q36963511-4375B4C0-B13B-4838-8D68-3B469B040ACC Q36973598-C268E740-EE70-400F-B282-4729D71301D8 Q37006521-CE7E95A9-1CEE-4869-B2D8-A75C78563692 Q37014032-E673FF3F-AF58-410F-AFFA-403413450DE1 Q37395475-6EEFDA07-3E64-47A0-B438-BF482ADC779E Q37488499-E77A6136-2FB1-427E-B771-F258DDE5B84C

P2860

Antiretroviral therapy refusal among newly diagnosed HIV-infected adults.

http://www.wikidata.org/entity/Q35737611

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Antiretroviral therapy refusal among newly diagnosed HIV-infected adults.

@ast

Antiretroviral therapy refusal among newly diagnosed HIV-infected adults.

@en

type

label

Antiretroviral therapy refusal among newly diagnosed HIV-infected adults.

@ast

Antiretroviral therapy refusal among newly diagnosed HIV-infected adults.

@en

prefLabel

Antiretroviral therapy refusal among newly diagnosed HIV-infected adults.

@ast

Antiretroviral therapy refusal among newly diagnosed HIV-infected adults.

@en

P1433

Q35737611-40E08A0F-57DC-4621-AE65-FD90C3149EBD

P1476

Q35737611-DC05F677-52D5-4917-9F25-335C70F0B8C8

P2093

Q35737611-3113B87E-29AC-4EAF-9575-761A0388FBAE

Q35737611-7B736CCC-31BF-4784-8EC5-CEEB9E382CBC

Q35737611-AFFAAF46-6C98-44B5-8D5D-8A8DA4E6408D

Q35737611-BD13B810-09DC-4DC4-B03B-C3DBEA4B4D8E

P2860

Q35737611-05D9563C-27C5-4EA9-BDD4-C7416A513CF3

Q35737611-0F3E317A-A91B-4CCF-AC45-95F5C06F912E

Q35737611-135D7A74-8811-4FC0-A9E0-86D13D816499

Q35737611-26308CAE-AD8D-4DCC-A584-5BC8936B9EE5

Q35737611-4E2A1A2A-923E-4929-BF4B-C0313ADB00E4

Q35737611-513DB8C9-B8EA-45EC-B86C-F595BE2C54A5

Q35737611-782C42F0-16E7-4E63-9953-44EE8EE2B652

Q35737611-8EAB39AE-4BF9-4DB8-BEBA-13C30DC08E1D

Q35737611-9EF40C13-04A4-4C8C-9EB4-52E02303289C

Q35737611-AFD06F93-8A0F-40B8-944A-D28E97D9DF52

P304

Q35737611-1C0B2375-CA29-42A6-AAC7-FCB58CA9D334

P31

Q35737611-748A4E3A-94B5-4824-8E8F-3120645DFA7B

P356

Q35737611-BABF6C4A-96C3-4155-8785-B2CD3CF3B03B

P407

Q35737611-9C55AE3A-27D1-4D9C-BCAD-DFA7F3200B56

P433

Q35737611-145B8744-1B00-45B9-97DC-612036E05D53

P478

Q35737611-8F2BBF68-E8D4-4228-9746-2B085C56E509

P50

Q35737611-27B2B454-5716-4173-A787-584066D2D0D2

Q35737611-29CFA1B2-A5D8-405B-ABBF-BAD16BC1A8F6

Q35737611-3902F377-728F-4FD1-9B81-2514C195DD36

P577

Q35737611-53406A91-DE59-46BD-8287-1294B05A413C

P698

Q35737611-6D7FDD73-1967-4A59-BB2C-8FB3241603A4

P921

Q35737611-9F6E9096-0E92-4D3B-B936-6E0C91B3127A

P932

Q35737611-1AE894B2-D792-49F8-AD44-D372BB1A03DB

P356

QAD.0B013E32834B6464

P1433

P1476

Antiretroviral therapy refusal among newly diagnosed HIV-infected adults.

@en

P2093

Edmore T Marinda

http://www.w3.org/2001/XMLSchema#string

Glenda E Gray

http://www.w3.org/2001/XMLSchema#string

Neil A Martinson

http://www.w3.org/2001/XMLSchema#string

Thandekile Essien

http://www.w3.org/2001/XMLSchema#string

P2860

HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.

Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport.

The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa.

Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa.

Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa

Timing of initiation of antiretroviral drugs during tuberculosis therapy.

Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.

HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies.

Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study

Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa

P304

2177-2181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E32834B6464

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

David R Bangsberg

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21832935

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3272300

http://www.w3.org/2001/XMLSchema#string